Immunohistochemistry (IHC) is crucial for the clinical categorisation of breast cancer cases. Deep generative models may offer a cost-effective alternative by virtually generating IHC images from hematoxylin and eosin samples. This review explores the…
Continue Reading
Accelerating Clinical Trials Through Automation and AI
The recruitment phase for clinical trials takes an average of 18 months, and nearly 20% of cancer trials fail because of low accrual rates. Automation and AI can…
Image Credit: b-rayZ
What You Should Know:
– Affidea, a pan-European provider of community-based polyclinics, specialist services, and advanced diagnostics, has announced a strategic collaboration with b-rayZ, a leader in AI-powered breast imaging solutions.
– The strategic…
Continue Reading
Memorial Sloan Kettering Cancer Center and UnitedHealthcare are locked in a high-stakes contract negotiation that could significantly impact cancer patients across the region. The renowned cancer treatment facility has issued warnings to patients about…
Continue Reading
[embedded content]
What You Should Know:
– Robovision Healthcare and the Netherlands Cancer Institute (NKI) have unveiled a pioneering AI solution, BrainMets AI, capable of detecting brain metastatic disease with unprecedented precision. The breakthrough research, published…
Continue Reading
Leah Dewey, VP of Clinical and Consumer Engagement Operations, Cotiviti
According to the Centers for Disease Control and Prevention (CDC), rural Americans have a higher risk of premature death from heart disease, cancer, respiratory disease,…
Continue Reading
Dana Brown, President and CEO of iCAD, a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions joins eHealth Radio and the…
Continue Reading
Denise Marks, CFO and EVP of CareQuest Institute for Oral Health
John T. McDevitt, PhD, Founder and Chief Scientist of OraLiva, INC.
Cancer is the second leading cause of death in the U.S., with cigarette use…
Continue Reading
Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its…
Continue Reading
Cancer research organization City of Hope has co-led a study to show that characterizing genetic material close to chromosomes predicts how mutated, cancer-causing genes reprogram DNA and alter the tumor microenvironment. City of Hope said…
Continue Reading
